Neuroscience & Biobehavioral Reviews, Vol. 4, pp. 77-86. Printed in the U.S.A.

The Role of Endorphins in Stress:

Evidence and Speculations
S HI MON AMI R , 2 Z AVI E W. B R OWN AND Z AL MAN AMI T
Center f or Research on Drug Dependence, Department of Psychology, Concordia University
1455 de Maisonneuve Blvd. West, Montreal, Quebec, Canada
Re c e i v e d 2 No v e mb e r 1979
AMIR, S., Z. W. BROWN AND Z. AMIT. The role of endorphins in stress: Evidence and speculations. NEUROSCI.
BIOBEHAV. REV. 4(1) 77-86, 1980.--Several lines of evidence suggest that the endogenous opioid peptides endorphins
may play a role in the defensive response of the organism to stress. The present paper summarizes these findings as well as
evidence linking endorph/ns to the anterior pituitary polypeptide hormone adrenocorticotropin (ACTH). Evidence is
presented that endorphins may function as trophic hormones in peripheral target organs such as the adrenal medulla and the
pancreas. As such they may be part of the physiological mechanisms that mediate adrenaline and glucagon release in
response to stress. Endorphins (enkephalins) are also suggested to play a role in the control of the pituitary gland during
stress. In such capacity they may act as hormone-releasing or inhibiting factors. Finally, endorphins appear to play a role in
the behavioral concomitants of stress. In such capacity eodorphins are suggested to function as modulators of neural
systems that mediate the elaboration and expression of the reactive/affective components of stress. Speculations on the
mode of interaction between eodorphins and ACTH in the global response to stress are discussed.
Stress Endorphins Enkephalins ACTH Opiate receptor
Analgesia Affect Pituitary gland
Adrenal medulla functioning Pain
THERE is growi ng awar eness t hat opi oi d pept i des
endorphi ns r epr esent a new cl ass of neurot ransmi t t ers and
modul at or s, c ommon t o t he cent ral and somat i c divisions of
t he ner vous and endocr i ne syst ems, and t hat t hey may serve
t o regulate neural and endocr i ne funct i ons t hat pl ay a rol e in
t he el aborat i on of adapt i ve behavi or [15, 25, 55, 68, 79, 119,
128, 130, 169, 170, 185, 228]. I t is becomi ng i ncreasi ngl y
evi dent , however , t hat t hese pept i de syst ems may not func-
t i on t oni cal l y but t hat t hey i nfl uence physi ol ogi cal and be-
havi oral pr ocesses in a r at her sel ect i ve manner , onl y under
specific envi r onment al condi t i ons or endogenous fact ors
(e.g. [1, 36, 42, 48, 49, 58, 62, 86, 89, 91, 95, 100, 109, 113,
127, 137, 142, 146, 157, 194, 230, 240]). Evi dence accumu-
lated r ecent l y indicate t hat endorphi ns are rel eased f r om
t he pi t ui t ary gland in r esponse t o st ress concomi t ant l y
with t he hor mone adr enocor t i cot r opi n ( ACTH) , and t hat
st ruct ural rel at i onshi ps exist bet ween t he t wo cl asses of
pol ypept i des [94,156]. Fur t her mor e, t here is evi dence t hat
st ress may act i vat e endorphi n syst ems in t he brain as well
[3,190]. These findings suggest t hat endorphi ns may pl ay a
rol e in t he global defensi ve r esponse t o st ress, and t hat their
physi ol ogi cal funct i oni ng may be rel at ed in some fashion t o
t he funct i ons t o t he hor mone ACTH. ACTH is known
pri mari l y f or its rol e in t he rel ease of st eroi d hor mones f r om
t he adrenal cor t ex and f or its di rect met abol i c effect s, whi ch
enabl e t he organi sm t o bet t er adj ust t o ext r eme changes in
ci r cumst ances [63,204]. Addi t i onal l y, ACTH possesses var-
i ous cent ral ner vous syst em effect s, whi ch are i ndependent
of its somat ot r opi c funct i ons, and it appears t o influence
mot i vat i on and arousal and ot her cent ral pr ocesses t hat play
a rol e in adapt i ve behavi or [33, 52, 56, 79, 130, 168].
I n t he present article we revi ew evi dence on t he involve-
ment o f endorphi ns in t he global r esponse o f t he organi sm t o
stress. We descri be findings t hat endorphi ns and ACTH are
part of t he same neur oendocr i ne syst em but t hat t hey may
normal l y pr oduce differential physi ol ogi c and behavi oral ef-
fect s. Fur t her mor e, we pr opose several hypot heses concer n-
ing a funct i onal link bet ween t he endorphi ns and physi ol og-
ical mechani sms t hat pl ay a role in stress. Finally we exam-
ine findings on t he role of endorphi ns in t he behavi oral re-
sponse t o st ress and suggest t hat t hey may medi at e t he elab-
orat i on and expressi on of t he react i ve/ affect i ve component s
of stress.
BIOCHEMICAL EVIDENCE FOR THE INVOLVEMENT OF
ENDORPHIN IN STRESS
The opioid pept i des betaoendorphin and enkephalin occur
in cells and pr ocesses of t he cent ral and aut onomi c ner vous
syst em and in t he cent ral and somat i c divisions of t he
endocri ne syst em. Bet a*endorphi n is f ound in t he pi t ui t ary
gland [14, 85, 106, 152, 195, 219], part i cul arl y in t he pars
i nt ermedi a and adenohypophys i s [24,188]. Addi t i onal l y, it
occur s within t he brai n, with a single cell gr oup in t he
hypot hal amus and large axons i nnervat i ng iimbic and mid=
brain st ruct ures [37,191]. Enkephal i n syst ems, with multiple
1Presented at a Workshop on Stress and Environmentally Induced Analgesia, Eastern Psychological Association annual meeting, Philadel-
phia, PA, April 1979.
~Present address: Isotope Department, Center for Neuroscience and Behavioural Research, The Weizmann Institute of Science, Rehovot,
Israel.
77
78 AMIR. BROWN AND AMIq
cell groups and relatively short axons occur within the brain
and spinal cord [23, 24, 59, 235], the gastrointestinal tract
[4,182], the pancreas [93], in sympathetic ganglia [53, 200-
202] and in many gland cells as well as in nerve fibers in the
adrenal medulla [147, 154, 201, 202]. Beta-endorphin and
enkephalin are fragments of the hormone beta-lipotropin
(endorphin: beta-lipotropin 61-91; enkephalin: beta-
lipotropin 61-65) [45,144]. This pituitary polypeptide hor-
mone [ 140,148] is contained within a 31,000-dalton glycopro-
tein molecule known as pro-opiocortin, which also contained
within its sequence the hormone ACTH [156, 186, 193].
Endorphins and ACTH are present within the same se-
cret ory granules in pituitary corticotrophic cells [ 178,238] and
there is immunocytochemical evidence that they also coexist
within the brain [37, 130, 131,151,235]. Furt hermore, there
is evidence that the same environmental and endogenous
stimuli trigger the mobilization of endorphins and ACTH
from the pituitary for physiological functioning and that the
same biochemical processes are regulating this effect. Stres-
sors known to activate the pituitary-adrenal axis (e.g. limb
fracture, foot shock, heat stress, insulin-induced hypo-
glycemia, ingestion of hypenoni c saline, immobilization) have
been reported to decrease anterior pituitary endorphin con-
tent and to trigger a parallel increase in pl asma endorphin
and ACTH levels [13, 22, 94, 132, 192, 198, 241]. A rise in
pl asma endorphin and ACTH levels has also been observed
following adrenal eet omy, met yrapone or morphine adminis-
tration, electroconvulsive t reat ment and in various patholog-
ical conditions related to pituitary hyperfunctioning [2, 61,
43, 66, 70, 77, 94, 105, 132, 231,241]. Both stress-induced
and morphine-induced release of endorphins and ACTH
were found to be blocked by the administration of the syn-
thetic glucocorticoid dexarnethasone and by hypophysec-
t omy [70,94]. In in vitro preparations, endorphins and ACTH
were found to be released from pituitary cells in response to
purified hypothalamic corticotropin releasing factor,
hypothalamic ext ract and lysine vasopressi n [94, 183,224].
This effect was found to be blocked by dexamet hasone and
by the administration of dopamine and its agonist apomor-
phine [223,224]. Alterations in brain levels of endorphins
have also been reported following exposure to stress. Foot
shock or heat stress have been shown to cause an increase
[3, 155, 240] or a decrease [190,192] in regional or whole
brain enkephalin content. However, failure to induce any
change in brain enkephalin content after such t reat ment has
also been reported [67]. Similarly, immobilization stress has
been reported not to produce any changes in hypothalamic
immunoreactive ACTH concentrations [129]. Repeated ex-
posure of immature rats to heat stress resulted in an increase
in endogenous opioid content and in opiate recept or binding
capacity in brain [221]. Finally, psychological stress (con-
ditioned fear) has been reported to result in an increase in
opiate recept or occupancy in brain, suggesting a possible
rise in peptide activity [39,40]. Social isolation, another form
of psychological stress resulted in an increase in the number
of opiate recept or binding sites in brain [34].
Taken together, the above findings suggest that activation
of endorphin syst ems may be an integral part of the global
defensive response of the organism to stress. Additionally,
the findings outlined suggest that endorphins and ACTH,
which appear to coexist in two distinct neuroendocrine sys-
t ems (i.e. pituitary and brain), may function in a coordinated
manner to mediate both the physiological and the behavioral
consequences of stress.
ENDOCRINE FUNCTIONS FOR ENDORPHIN DURING STRESS
The fact that endorphin is released from the pituitary to
the circulation in response to stress suggests that it may
function as at r ophi c hormone at peripheral target organs,
and that like ACTH, it may modulate the activity of
endocrine syst ems that play a role in stress. Several studies
suggest that endorphins may play a role in the control of
catecholamine release from the adrenal medulla. Stress-
induced adrenaline release from the adrenal medulla is con-
trolled predominantly by trans-synaptic input from the
splanchnic nerve [38, 139, 176, 220]. Morphine has been
shown to influence adrenaline synthesis and storage and to
stimulate adrenaline release from the adrenal medulla di-
rectly, even after chronic and complete denervation of this
gland [10, 11,248]. Furt hermore, a population of high affinity
opiate binding sites with sensitivity to sodium ions similar to
that of brain opiate receptors has been described in bovine
adrenal medulla [41]. It is conceivable that circulating
endorphins could exert exclusive morphine-like adrenaline
releasing effects via opiate recept or systems in the adrenal
medulla and that this physiological mechanism may function
in parallel to the sympatho-adrenal axis that normally control
adrenaline release. Indeed, a hypothalamo-anterior pituitary
syst em that modify adrenaline release from the adrenal
medulla has been described [12,138] and endorphin has been
shown to act as a trophic hormone in kidney tissue [96].
Furt hermore, the presence of enkephalins in sympathetic
ganglia [53,200-202] and in cells and nerve terminals in the
adrenal medulla [147, 154, 199, 201,202,211] suggest a role
for opioid peptides in the neural control of the adrenal
medulla. Enkephalins could interact with adrenaline-release
mechanisms after they have been secreted from the splan-
chnic nerve in response to stress along with other transmitter
substances (i.e. acetylcholine) that play a role in the control
of adrenaline release from the adrenal medulla. Alterna-
tively, enkephalin could be released from the adrenal
medulla and act on "opi at e- aut or ecept or s" on the gland ceil,
to regulate adrenaline secretion in response to stress. Fi-
nally, enkephalins could be released from the adrenal
medulla into the circulation concomitantly with adrenaline
and exert hormone-like effects at other target organs. It
should be noted that despite the rapid enzymatic degradation
of enkephalin and the reported lack of analgesic effects fol-
lowing intravenous administration of the peptide [98], pe-
ripherally secreted enkephalins could still play some, as yet
unidentified physiological or behavioral role in stress. This
possibility is backed by the findings that systemic adminis-
tration of enkephalins to experimental animals may result in
behavioral change [119].
Endorphins may also play a role in the control of the
hypothalamo-pituitary-adrenal cortex axis. Endorphins and
opiates have been reported to stimulate in vitro corticos-
terone synthesis [74,206]. Since some opiate receptor bind-
ing sites occur in the adrenal cortex [41 ] it is conceivable that
endorphin, like ACTH, could exert some corticotropic ef-
fects in animals, when released into the circulation in re-
sponse to stress. Alternatively, endorphin or enkephalin
could play a role in modulating stress-induced secretion of
adrenal steroids indirectly, by stimulating or reducing a
restraint on ACTH release from the pituitary gland. The re-
lease of ACTH in response to stress is triggered by the action
of corticotropin releasing fact or (CRF) on the pituitary gland
[197,229]. CRF is located in neurosecretory cells in the su-
ROLE OF ENDORPHI NS IN STRESS 79
praoptic and periventricular nuclei of the hypothalamus, where
high content of opiate recept ors and of enkephalin and
endorphin immunoreactive material has been reported [37,
59, 136] and where stress-induced changes in enkephalin
levels have been observed [190,192]. The opiate antagonists
naloxone and naitrexone have been shown to block stress-
induced corticosterone release in mice [75, 76, 78] while
endorphin has been reported to induce ACTH secretion from
the pituitary in rats [225]. Taken together, these data suggest
that hypothalamic opioids may play a role as corticotropin
releasing agents or that they interact with other factors (i.e.
CRF) that play a more direct mediational role in the release
of ACTH in response to stress. Interestingly, evidence ac-
cumulated in recent years strongly supports the notion that
multiple releasers rat her than a unique neurohormone is
mediating the secretion of ACTH from the pituitary during
stress [197].
Opiate recept ors occur in the pituitary gland, particularly
in the post eri or (neural) lobe, and in the pancreas [108,207].
Furthermore, enkephalin containing neurons project from
the hypothalamus to the neural lobe [189], and enkephalin-
like immunoreactivity has been found in pancreatic glucagon
cells [93]. These findings suggest a role for opioid peptides in
the control of hormones such as vasopressin, glucagon and
insulin which play a role in the global response to stress [107,
108, 116, 158,239]. Finally, endorphin and enkephalin have
been reported to play a role in the release of the anterior
pituitary hormones prolactin and growth hormone, which
also play a role in the response to stress [35, 58, 84, 88, 149,
161, 205, 226]. The findings outlined above suggest that
endorphins may play a role in the control of hormone secre-
tion in both the central (i.e. pituitary hormones) and periph-
eral (i.e. adrenal and pancreas hormones) divisions of the
endocrine system. In addition they suggest a rink between
enkephalin and component s of the central and autonomic
nervous syst em that trigger hormone release from these
endocrine syst ems in response to stress. Thus the findings
suggest that endorphin and enkephalin may be part of the
diffuse neuroendocrine syst em that may account for the
coordinated secretion of hormone substances during stress.
This idea fits well with the findings that endogenous opioids
and ACTH are mobilized simultaneously in response to
stress and it supports the notion that the t wo classes of pep-
tides exert parallel trophic effects as pa n of the adaptive
response to stress.
BEHAVIORAL ROLE FOR ENDORPHIN DURING STRESS
The formation and execution of adaptive behavi or de-
pends to a large extent on a well coordinated interplay be-
tween neural syst ems that mediate sensory, motivational and
affective processes within the brain. Endorphins possess
central nervous syst em effects [68, 169, 171] and there is
evidence that t hey may play a role in the elaboration and
expression of the emotional response to stress.
Acute exposure to stressors such as electric shock, cold
wat er swim, restraint, insulin-induced hypoglycemia, as well
as psychological stress has been reported to modify pain
responsi veness in a large number of laboratory studies [ 125].
Stress-induced analgesia was subsequently found to depend
on the functional integrity of the pituitary gland [6, 27, 28,
102], to correlate with changes in endorphin activity [3,155]
and opiate recept or occupancy in the brain [39,40], and to be
blocked, in pan, by the opiate antagonist naloxone [3, 9, 29,
30, 42]. Hypnot i c analgesia in conditions of stress was also
partially reversed by naioxone [71], but no effect of naloxone
~: ~obs e r ve d in ot her ~ases of hypnotic analgesia [87,159].
The changes in pain responsiveness induced by stress re-
sembled the analgesia induced by morphine [42] as well as
that induced by exogenously administered endorphins [222],
suggesting an opi at e like role for endogenous endor-
phin/enkephalin syst ems in such effect [26,209]. Evi-
dence from human studies suggest that a well defined sep-
aration exists between the peripheral or internal sensation of
pain and the central elaboration of that sensation (i.e. the
emotional component of pain) [18,163]. Since morphine has
been shown to exert its analgesic effects primarily by mod-
ifying the emotional component of pain [111,167] it is con-
ceivable that stress-induced analgesia, which presumably
acts at least in part via endorphin release, may exert com-
parable selective effects. When placed on a hot metal plate
(51C) within a Plexiglas enclosure rats typically exhibit two
distinct behavioral responses: a paw withdrawal accom-
panied by vigorous licking, and jumping t hat ultimately leads
to escape. Analysis of the temporal relationships between
the two response latencies suggest that the paw lick response
(short latency) may represent the sensory/perceptual com-
ponents of pain while the escape behavi or (long latency) may
represent the reactive/affective component s of pain [9,69].
Using this paradigm it was reported that immobilization
stress, which induces the release of endorphins from the
pituitary gland [13, 57, 124], had a selective effect on escape
but it did not influence paw lick behavi or [6,9]. In these
studies naloxone or hypophysect omy blocked the effect of
immobilization stress on escape but they did not influence
paw lick behavior. Elsewhere, naloxone was reported to
exert selective effects on jumping from a hot plate in mice,
suggesting that hot piate-stress may be sufficient to activate
endorphin syst ems so that previous exposure to stress may
not be necessary to demonst rat e a selective involvement of
endorphins in the affective component of pain [6, 27, 28,
102]. Finally, chronic administration of the opiate antagonist
naltrexone resulted in enhanced sensitivity to foot shock-
induced attenuation of escape from a hot plate in rats [5].
Chronic opiate receptor blockade was found previously to
increase the number of opiate receptor binding sites in the brain
as well as to result in supersensitivity to the analgesic effect
of morphine [141,212]. Interestingly, acute stress has been
shown to potentiate the hyperalgesic effect of naloxone [118]
as well as i t ' s ability to antagonize morphine analgesia
[99,245] while hypophysect omy has been reported to block
the hyperalgesic effect of naloxone [90]. Naloxone was
found to induce contractions in ileum preparations taken
from stressed guinea pigs, but it failed to do so in ileum
preparations t aken from non s t r es ~d animals [32].
Unlike acute stress, which typically reduces pain respon-
siveness, prolonged exposure to stress (anxiety) could lead
to enhanced reactivity to pain [16, 17, 184]. Such effect may
be linked to a chronic reduction in the functional availability
of endorphin [203], or to a change in endorphin/ACTH ratio.
Stress-induced analgesia adapts upon repeated exposure to
the stressor [9,31], and such treatment may also lead to
hyperresponsi veness to pain and to a decreased endorphin
activity in brain [155]. Furt hermore, ACTH administration
to normal or hypophysect omi zed-st ressed rat s enhanced es-
cape from a hot plate [6]. Additionally, such t reat ment par-
tially reversed the analgesic effect of cold wat er swim [46].
Finally, chronic elevated plasma levels of ACTH, induced
by adrenalectomy was associated with increased sensitivity
to pain in rats [102].
80 AMIR, BROWN AND AMIT
Other studies also provide evidence that endorphin systems
may play a role in modifying emotional tone during stress.
Thus, endorphins or enkephalins has been suggested to be
released in response to a stimulus that signalled shock [39,40]
while naloxone was found to block animal's preference for a
signalled versus unsignalled shock [64]. Naloxone has also
been shown to enhance shock induced freezing in rats [65] al-
though failure of naloxone to influence the fear-induced im-
mobility reflex in rabbits [73] or the fear induced startle re-
sponse in rats [50] has also been observed. Exposure of ani-
mals to a novel environment is a stressful event and the
amount of exploration and activity under such circumstances
could be used as a measure of emotional tone. A direct corre-
lation was demonstrated between exploratory behavior in
mice and enkephalin induced behavioral activation in these
animals [123]. Furthermore, naloxone or naltrexone were
found to depress exploratory behavior and entry into a novel
environment in mice and rats [92, 121,123]. Finally, chronic
administration of naloxone prevented the increase in activity
seen in rats upon repeated exposure to the testing environ-
ment [8]. Some stressful situations with an apparent emo-
tional component may lead to changes in body temperature
(emotional hyperthermia). Such changes are linked to an in-
crease in plasma endorphin-like immunoreactivity and they
are found to be blocked by the opiate antagonist naloxone
[22]. Interestingly, endorphins have been suggested to play a
role in behavioral adaptation to heat stress [104], while noise
stress has been shown to mask the hypothermic effect of
naloxone in rats [210]. Non-traumatic noice-light stress has
also been shown to increase grooming behavior in a novel
environment [122]. This effect was found to be blocked by
naltrexone, suggesting the involvement of an endogenous
opioid system in the expression of stress induced grooming
[82,122]. Finally, endorphins have been reported to reduce
distress vocalization in socially isolated chicks [175] while
naloxone was found to increass such behavior in guinea pigs
[101]. These studies suggested a role for endogenous opioids
in mediating the affective component of social stress
[34,174]. In humans, naloxone and naltrexone were found to
exert negative effects on mood [162,214].
The evidence summarized in this section suggest that the
elaboration and manifestation of behavior under conditions
of stress may be linked to the function of endogenous opioid
systems. More specifically, they suggest that endorphin may
play a rather selective role in the elaboration of emotion
during stress. The endorphin-induced changes in emotional
tone do not depend on the presence of any particular stres-
sor. Indeed, endorphins are mobilized from the pituitary and
in the brain in response to a large number of unrelated stres-
sors including electric shock, restraint, leg fracture, insulin-
induced hypoglycemia and more [13, 22, 94, 132, 192]. Fur-
thermore, such changes may possess different behavioral
consequences. Changes in emotional-tone in response to
stress probably possess an adaptive value since they may
enable the organism to better adjust to those stressful cir-
cumstances that induced endorphin release. Such effect
would be of particular importance in the case of stressors
that involve physical injury (i.e. acute analgesia). Inter-
estingly, the response to some forms of pain may not depend
on activation of endogenous opioid systems. While several
experiments have demonstrated lower pain resistance fol-
lowing naloxone administration, thus implicating endorlahins
in the normal response to pain [36, 43, 69, 109, 127, 146],
others have failed to demonstrate such effect [86, 89, 100,
1711.
Changes in endorphin activity may also lead to maladap-
tive consequences. For example, if endorphin release per-
sists in the presence of a stressor, a condition which may
result from a defect in feed back control, the development
and execution of goal directed behavior (i.. fight, escape)
may be disrupted. Indeed, changes in affective-tone are
common characteristics of certain stress related pathological
conditions in humans (i.e. schizophrenia, depression), and it
may be linked to an abnormal activation of endorphin sys-
tems in response to stress [228]. Reports of high plasma and
CSF endorphin levels [54, 150, 214,216,233] and of reduced
sensitivity to pain [47,97] in humans suffering from affective
illness, and of the beneficial effect of naloxone in such con-
ditions [62, 95, 145, 214, 234] give support to such idea.
However, the existence of contradictory evidence narrows
the generality of such effect [1, 49, 61, 113, 137, 187, 230].
A coordinated role for pituitary endorphin and ACTH in
the behavioral response to stress is suggested from the find-
ings that they are released from anterior pituitary corticotrophs
in parallel in response to stress, and that the same regulatory
mechanisms are mediating the release of these peptides I94].
Pituitary endorphin and ACTH represent a distinct system
that is separated from brain endorphin and ACTH [44. 126,
129, 133, 191, 200]. It is conceivable however that small
amounts of these peptides may enter the brain via the vascu-
lar system or through the CSF after being mobilized from the
pituitary during stress [19, 20, 119, 130, 167, 172, 180, 227].
In addition, endorphin (enkephalin) may be mobilized in re-
sponse to stress within the brain [155]. Endorphin and
ACTH could exert opposing effects via the same receptor
mechanisms and function as regulators of neural systems
that mediate adaptive behavior during stress. ACTH, like
endorphins, possess affinity for opiate receptors in vitro [81,
215,217,218, 242, 249]. Furthermore, ACTH was found to
counteract morphine analgesia [81, 83,242,244] as well as to
antagonize morphine-induced behavioral activation in mice
[120]. Moreover, ACTH was found to antagonize the
morphine-induced reduction in spinal reflex activity in the
cat and the depressant action of morphine on monosynaptic
activity of frog isolated spinal cord in vitro [135,249]. Fi-
nally, ACTH fragments were found to mimic the inhibitory
effect of morphine on the electrically evoked contraction of
the mouse vas deferens [181]. This effect as well as the effect
of ACTH on grooming behavior and reproductive function
was found to be blocked by naloxone and naltrexone [80, 82,
115, 181, 247] although a synergistic effect of naloxone on
ACTH [21] or no interaction between ACTH and naltrexone
has also been observed I51]. Finally, naloxone was found to
block ACTH intravenous self-administration in rats [117].
The above findings provide evidence for the existence of a
common site of action for endorphins and ACTH [7, 134,
232, 242]. They also suggest that ACTH may function in the
capacity of an endogenous antagonist for opiate receptor
systems in the brain [134,217,218,242]. Opposing effects of
endorphins and ACTH on neural excitability [165, 170, 196,
243,246] and neurotransmitter functioning in the brain [114,
153, 166, 213] have been demonstrated.
Additionally, endorphins and ACTH may function via
separate neural systems in the brain [110]. Endorphin or
enkephalin may modulate the function of limbic mechanisms
that play a role in the elaboration of emotion. The occur-
rence of dense population of opiate receptors [136, 143, 179]
and of opioid neurons in limbic structures [103, 208, 237],
and their interaction with central catechotamine neurons [72]
is in line with such idea. Furthermore, the occurrence of
ROLE OF ENDORPHINS IN STRESS 81
ACTH containing neurons in the hypothaiamus, thalamus,
midbrain, amygdaia and reticular formation [173, 177, 236]
suggest the presence there of ACTH receptor systems, and it
is in line with the proposed role of ACTH of central or pitui-
tary origin in the central mediation of motivation and arousal
during stress [33,160].
The research on endorphins outlined above suggests that
these opiate-like peptides may play a role in the global re-
sponse of the organism to stress. Endorphi ns appear to be
part of a diffuse neuroendocrine system that also contains
the hormone ACTH. Endorphins and ACTH appear to func-
tion in parallel in peripheral target organs and in the brain. In
particular, endorphins may function as trophic hormones, to
stimulate adrenaline release, or as releasing or inhibiting fac-
tors in the pituitary gland. In the brain endorphins may func-
tion to modulate neural systems that play a role in the elab-
oration and expression of the emotional component s of be-
havior during stress.
The proposed behavioral role of endorphins in the media-
tion of emotion during stress is analogous to the observed
analgesic effects of exogenously administered opiates. As
discussed, opiates appear to exert selective effects on the
affective component of pain, leaving the sensory component
relatively infact. Similarly, the endogenous opiate system
may serve to modulate the affective reaction to stressful
stimuli while ACTH may be involved in the perception of
that stimuli and in preparatory functions that lead to the
response. In view of the fact that endorphins and ACTH are
released from the pituitary simultaneously in response to
stress, a coordinated action of endorphin and ACTH would
allow for the production of adaptive behavior.
ACKNOWLEDGEMENTS
We would like to thank Miss King-Yee Man for careful typing of
the manuscript. Dr. Shimon Amir was supported by the Medical
Research Council of Canada. Dr. Zavie Brown was supported by the
National Research Council of Canada.
REFERENCES
1. Abrams, A., D. Braff, D. Janowsky, S. Hall and D. Segal.
Unresponsiveness of catatonic symptoms to naloxone. Phar-
makopsychiatry 11: 177-179, 1978.
2. Akil, H., S. J. Watson, J. D. Barchas and C. H. Li.
b-Endorphin immunoreactivity in rat and human blood:
radioimmunoassay, comparative levels and physiological al-
terations. Life Sci. 24: 1659--1666, 1979.
3. Akil, H., J. Madden, R. L. Patrick and J. D. Barchas. Stress-
induced increase in endogenous opiate peptides: Concurrent
analgesia and its partial reversal by naloxone. In: Opiates and
Endogenous Opioid Peptides, edited by H. W. Kosterlitz.
Amsterdam: North Holland, 1978, pp. 63-70.
4. Alumets, J., R. Hakansson, F. Sundler and K. I. Chang. Leu-
enkephaiin-like material in nerves and enterochromaffin cells
in the gut. Histochemistry 56: 187-196, 1978.
5. Arnir, S. and Z. Amit. Enhanced analgesic effects of stress
following chronic administration of naltrexone in rats. Eur. J.
Pharmac., in press.
6. Amir, S. and Z. Amit. The pituitary gland mediates acute and
chronic pain responsiveness in stressed and non-stressed rats.
Life Sci. 24: 439-448, 1979.
7. Amir, S., R. Blair, P. Shizgal and Z. Amit. Dual mechanism
mediating opiate effect? Science 205: 424--425, 1979.
8. Amir, S., M. Solomon and Z. Amit. The effect of acute and
chronic naloxone administration on motor activation in the rat.
Neuropharmacology 18: 171-173, 1979.
9. Amir, S. and Z. Amit. Endogenous opioid ligands may mediate
stress-induced changes in the affective properties of pain re-
lated behavior in rats. Life Sci. 23: 1143-1152, 1978.
10. Anderson, T. R. and T. A. Siotkin. The role of neural input in
the effects of morphine on the rat adrenal medulla. Biochem.
Pharmac. 25: 1071-1074, 1976.
11. Anderson, T. R. and T. A. Slotkin. Effects of morphine on the
rat adrenal medulla. Biochem. Pharmac. 24: 671-679, 1975.
12. Axelrod, J. Dopamine-beta-hydroxylase: Regulation of its syn-
thesis and release from nerve terminals. Pharmac. Rev. 24:
233-243, 1972.
13. Baizman, E. R., B. M. Cox, O. H. Osman and A. Goldstein.
Experimental alterations of endorphin levels in rat pituitary.
Neuroendocrinology 20: 402-424, 1979.
14. Baizman, E. R. and B. M. Cox. Endorphin rat pituitary glands:
Its distribution within the gland and age related changes in
gland content in male and female rats. Life Sci. 22: 519-526,
1978.
15. Barchas, J. D., H. Akil, G. R. Elliott, R. B. Holman and S. J.
Watson. Behavioral neurochemistry: Neuroregulators and be-
havioral states. Science 200: 964-973, 1978.
16. Barsky, A. J. III. Patients who amplify bodily sensations. Ann.
Int. Med. 91: 63-70, 1979.
17. Beecher, H. K. Relationship of significance of wound to pain
experience. J. Am. Med. Ass. 161: 1609-1613, 1966.
18. Beecber, H. K. Subjective response and reaction to sensation:
reaction phase as effective site for drug action. Am. J. Med. 20:
107-113, 1956.
19. Bergland, R. M. and R. B. Page. Pituitary-brain vascular rela-
tions: A new paradigm. Science 204: 18-24, 1979.
20. Bergland, R. M. and R. B. Page. Can the pituitary secrete
directly to the brain? (Affirmative anatomical evidence) Endo-
crinology 102: 1325-1338, 1978.
21. Bertolini, A., S. Senedani and M. Castelli. Behavioral effects
of naioxone in rats. Experimentia 34: 771-772, 1978.
22. Blasig, J., V. Hollt, U. Baverle and A. Herz. Involvement of
endorphin in emotional hyperthermia of rats. Life Sci. 23:
2525-2532, 1978.
23. Bloom, F., E. Battenberg, J. Rossier, N. Ling and R. Guille-
min. Neurons containing b-endorphin in rat brain exist sepa-
rately from those containing enkephalin: Immunohistochemical
studies. Proc. natn. Acad. Sci. U. S. A. 75: 1591-1595, 1978.
24. Bloom, F. E., E. Battenberg, J. Rossier, N. Ling, J. Lep-
paluoto, T. M. Vargo and R. Guillemin. Endorphins are located
in the intermediate and anterior lobes of the pituitary gland, not
in the neurohypophysis. Life Sci. 20: 43--48, 1977.
25. Bloom, F., D. Segal, N. Ling and R. Guillemin. Endorphins:
profound behavioral effects in rats suggest new etiological fac-
tors in mental illness. Science 194: 630-632, 1976.
26. Bodnar, R. J., D. D. Kelly, M. Brutus and M. Glusman.
Stress-induced analgesia: A review of neural and hormonal
mechanisms. Neurosci. Biobehav. Rev. 4: 87-100, 1980.
27. Bodnar, R. J., D. D. Kelly, A. Mansour and M. Glusman.
Differential effects of hypophysectomy upon analgesia induced
by two glucoprinvic stressors and morphine. Pharmac.
Biochem. Behav. 11: 303-308, 1979.
28. Bodnar, R. J., M. Glusman, M. Brutus, A. Spiaggia and D. D.
Kelly. Analgesia induced by cold-water stress: attenuation fol-
lowing hypophysectomy. Physiol. Behav. 23: 53-62, 1979.
29. Bodnar, R. J., D. D. Kelly, A. Spiaggla, C. Ehrenberg and M.
Glusman. Dose-dependent reductions by naloxone of analgesia
induced by cold water stress. Pharmac. Biochem. Behav. g:
667-672, 1978.
30. Bodnar, R. J., D. D. Kelly, A. Spiaggia, C. pavlides and M.
Glusman. Stress-induced analgesia: Effect of naloxone follow-
ing cold water swims. Bull. Psychon. Soc. 12: 125-128, 1978.
82 AM1R, BROWN AND AMI T
31. Bodnar, R. J. , D. D. Kelly, A. Spiaggia and M. Glusman.
Stress-inducnd analgesia: Adaptation following chronic cold
water swims. Bull. Psychon. Soc. 11: 337-340, t978.
32. Bodycot e, I. J. and G. B. Chesher. Nal oxone induced contrac-
ture of ileum from stressed guinea pigs. Eur. J. Pharmac. 57:
259-261, 1979.
33. Bohus, B. Effects of ACTHdi ke neuropcptides on animal be-
havior and man. Pharmacology 18:113-122, 1979.
34. Bonnet, K. A. , J. M. Hiller and E. J. Simon. The effect of
chronic opiate treatment and social isolation on opiate recept or
in the rodent brain. In: Opiates and Endogenous Opioid Pep-
tides, edited by H. W, Kosterlitz. Amsterdam: Nort h Holland,
1976, pp. 335-344.
35. Bruni, J. F. , D. Van Vugt, S. Marshall and J. Meites. Effect of
naloxone, morphine and methionine enkephalin on serum pro-
lactin, luteinizing hormone, follicle stimulating hormone,
thyroid stimulating hormone and growth hormone. Life Sci. 21:
461--466, 1977.
36. Buchsbaum, M. S., G. C. Davis and W. E. Bunney. Nal oxone
alters pain perception and somat osensory evoked potential in
normal subjects, Nature 270: 620--622, 1977.
37. Bugnon, C., B. Block, D. Lenys and D. Fellmann. Infundibular
neurons of the human hypothalamus simultaneously react i ve
with antisera against endorphins, ACTH, MSH and bet a-LPH.
Cell Tissue Res. 199: 177-196, 1979.
38. Canon, W, B. Bodily changes in pain, hunger, fear and rage.
In: Ciba Foundation Colloquia on Endocrinolo~'. New York:
Appleton, 1915, pp. 1-12.
39. Chance, W. T. , A. C. White, G. M. Kr ynoek and J. A. Rose-
t rans. Conditional fear-induced antinociception and decreased
binding of (3H) N-Leu-enkephal i n to rat brain. Brain Res. 141:
371-374, 1978.
40. Chance, W. T. , A. C. White, G. M. Kr ynock and J. A. Rose-
crans. Autoanalgesia: behaviorally activated antinociception.
Eur. J. Pharmac. 44: 283-284, 1977.
41. Chavkin, C., B. M. Cox and A. Goldstein. Stereospecific
opiate binding in bovi ne adrenal medulla. Molec. Pharmac. 15:
751-753, 1979.
42. Chesher, G. B. and B. Chart. Foot shock induced analgesia in
mice: its reversal by naloxone and cross tolerance with mor-
phine. Life Sci. 21: 1569--1574, 1977.
43. Csontos, K. , M. Rust, V. Hollt, W. Mahr, W. Kromer and H.
J. Teschemacher. El evat ed plasma beta-endorphic levels in
pregnant women and their neonates. Life Sci. 25: 835-844,
1979.
44. Cheung, A. L. and A. Goidstein. Failure of hypophysect omy to
alter brain cont ent of opioid peptides (endorphin$). Life Sci. 19:
1005-1008, 1976.
45. Crine, P., S. Benjannet, N. G. Seidah, M. Lis and M. Chretien.
In vitro biosynthesis of bet a endorphin in pituitary gland. Proc.
natn. Acad. Sci. U. S. A. 74: 1403-1406, 1977.
46. Criswell, H. E. and M. David. Partial antagonism of stress
induced analgesia by ACTH pretreatment. Soc. Neurosci.
Abstr. 5: 1768, 1979.
47. Davis, G. C. , M. S. Buchshaum and W. E. Bunney. Analgesia
to painful stimulation in affective illness. Am. J. Psychiat. 136:
1148-1151, 1979.
48. Davis, G. C. , M. S. Buchsbaum and W. E. Bunney Jr.
Nai oxone decreases diurnal variation in pain sensitivity and
somatosensory evoked potentials. Life Sci. 23: 1449-1460,
1978.
49. Davis, G. C., W. E. Bunney, E. G. DeFrai t es, J. E. Kleinman,
D. P. van Kammer , R. M. Post anti R. J. Wyatt. Intruveoous
naloxone administration in schizophrenia and ~r ect i ve illness.
Science 197: 74-77, 1977.
50. Davis, M. Morphine and naloxone: effects on conditioned fear
as measured with the potentiated startle paradigm. Fur. J.
Pharmac. 54: 341-347, 1979.
51. De Wied, D. , B. Bohus, J. M. Van Ree and I. Urban. Behav-
ioral and electrophysiological effects of l ~ p t i ~ s related to
lipotropin (b-LPH). J. Pharmac. exp. Ther. 204: 570-580, 1978.
52. De Wied, D., A. Witter and H. M. Greven. Behaviorally active
ACTH analogues. Biochem. Pharmac. 24: 1463--1468, 1975.
53. Di Guilio, A. M. , H. Y. T. Yang, B. E. Lutold, W. Fratta and
E. Costa. On the enkephalin content of sympathetic ganglia.
The Pharmacologist 20: 167, 1978.
54. Domschke, W., A. Dickschas and P. Mitznegg. C. S. F. beta-
endorphin in schizophrenia. Lancet 1: 1024, 1979.
55. Donovan, B. T. The behavioral actions of the hypothalamic
peptides: a review. Psychol. Med. 8: 305--316, 1978.
56. Dunn, A. J. and W. H. Gispen. How ACTH acts on the brain.
Biobehav. Rev. 1: 15--23. 1977.
57. Dunn, J. D. , W. J. Schindler, M. D. Hutchins, L. E. Scheving
and C. Turpen. Daily variation in rat growth hormone concen-
tration and effect of stress on periodicity. Neuroendocrinology
13: 69--78, 1974.
58. Dupont, A., L. Cusan, M. Garon, F. Labrie and C. H. Li.
b-Endorphin: Stimulation of growth hormone release in vivo.
Proc. hath. Acad. Sci. U. S. A. 74: 358-359, 1977.
59. Elde, R., T. Hokfelt, O. Johansson and L. Terenius. lm-
munohistochemical studies using antibodies to leucine-
enkephalin: Initial observations on the nervous system of the
rat. Neuroscience 1: 349--355, 1976.
60. Elsobky, A. , J. O. Dostrovsky and P. D. Wall. Lack of effect of
naloxone on pain perception in humans. Nature 263: 783-784.
1976.
61. Emrich, H. M., V. Hollt, W. Kissling, M. Fischler, H. Laspe,
H. Heinemann, D. V. Zerssen and A. Herz. beta-Endorphin-
like immunoreactivity in cerebrospinal fluid and plasma of
patients with schizophrenia and ot her neuropsychiatric disor-
ders. Pharmakopsychiatry 12: 269--276, 1979.
62. Emrich, H. M., C. Cording, S. Piree, A. Kolling, D. V. Zerssen
and A. Herz. Indication of an antipsychotic action of the opiate
antagonist naloxone. Pharmakopsychiatry 10: 265--270, 1977.
63. Engel, F. L. and H. E. Liebovitz. Ext ra target organ actions of
anterior pituitary hormones. In: The PituitaD" Gland, Vol. 2_
edited by G, W. Harris and D. T. Donovan. London: But-
terworths, 1966, pp. 563-588.
64. Fanselow, M. S. Nal oxone attenuates rat ' s preference for
signaled shock. Physiol. Psychol. 7: 70-74, 1979.
65. Fanselow, M. S. and R. C. Bolles. Nal oxone and shock elicited
freezing in the rat. J. cornp, physiol. Psychol. 93: 736-733,
1979.
66. Fischer, J. and C. Moriarty. Control of bioactive corticotropin
release from neuro-intermedia lobe of the rat. Endocrinology
100: 1047-1054, 1977.
67. Fratta, W. , H. Y. Yang, J. Hong and E. Costa. Stability of met-
enkephalin content in brain structures of morphine dcl)end-
ent or foot shock-stressed rats. Nature 2611." 452--453, 1977.
68. Frederi ckson, R. C. A. Enkephalin pental)eptides: A review of
current evi dence for a physiological role in vertebrate neuro-
transmission. Life Sci. 21: 23--42, 1977.
69. Frederickson, R. C. A., V. Burgis and J. D. Edwards.
Hyperalgesia induced by naioxone follows diurnal r h~hm in
responsivity to painful stimuli. Science 1911: 756--758, 1977.
70. French, E. D. , F. E. Bloom, C. Rivier, R. Guillemin and J.
Rossier. Morphine or stress induced increases of plasma
b-endorphin and prolactin are prevented by dexamethason pre-
treatment. Soc. Neurosci. Abstr. 4: 1285, 1978.
71. Frid, M. and G. Singer. Hypnotic analgesia in conditions of
stress is partially reversed by naloxone. Psychopharmacology
63: 211-215, 1979.
72. Fuxe, K. , K. Andersson, T. Hokfelt, V. Mutt, L. Ferland, L.
F. Agnati, D. Ganten, S. Said, P. Eneroth and J, A. Gas-
tafsson. Localization and possible function of peptidergic
neurons and their interactions with central categhohmaine
neurons, and the central action of gut hormones. Fedn~ Proc.
38: 2333-2340, 1979.
73. Galeano, C. , R. Morcos, R. Cloutier, P. A. Desmarais and P.
Beaudry. The immobility reflex: Effect of naioxone. Life Sci.
23: 61-64, 1978.
ROLE OF ENDORPHI NS IN STRESS 83
74. Gibson, A., M. Ginsburg, M. Hall and S. L;Hart. The effect of
opioid drugs and of lithium on steroidogenesis in rat adrenal
cell suspensions. Br. J. Pharmac. 65: 671-676, 1979.
75. Gibson, A., M. Ginsburg, M. Hall and S, L. Hart. The effects
of opiate receptor agonists and antagonists on stress-induced
secretion of corticosterone in mice. Br. J. Pharmac. 65: 139-
146, 1979.
76. Gibson, A., M. Ginsburg, M. Hall and S. L. Hart. The effect of
intracerebroventricular administration of methionine-enkepha-
iin on the stress-induced secretion of corticosterone in mice. Br.
J. Pharmac. 66: 164-166, 1979.
77. Gibson, A., M. Ginsburg, M. Hall, S. L. Hart and I. Kitchen.
Adrenalectomy changes endogenous opioid content in rat
hypothalamus. In: Charact eri st i cs and Funct i ons o f Opioids,
edited by J. M. Van Ree and L. Terenius. Amsterdam: Elsevier
North Holland, 1978, pp. 275-276.
78. Gibson, A., M. Ginsburg, M. Hall and S. L. Hall. The influ-
ence of naloxone and normorphine on plasma corticosteroid
levels in normal and stressed mice. J. Physi ol . 270: 28-29,
1977.
79. Gispen, W. H., J. M. Van Ree and D. De Wied. Lipotropin and
the central nervous system. Int . Rev. Neurobi oL 20: 209-250,
1977.
80. Gispen, W. H. and W. M. Wiegant. Opiate antagonists suppress
ACTH~_24-induced excessive grooming in the rat. Neurosci .
Let t . 2: 159-164, 1976.
81. Gispen, W. H., J. Buitelaar, V. M. Wiegant, L. Terenius and
D. De Wied. Interaction between ACTH fragments, brain
opiate receptors and morphine-induced analgesia. Fur. J.
Pharmac. 39: 393-397, 1976.
82. Gispen, W. H., V. M. Wiegant, A. F. Bradbury, E. C. Hulme,
D. G. Smyth, C. R. Snell and D. De Wied. Induction of exces-
sive grooming in the rat by fragments of lipotropin. Nat ure 264:
794-795, 1976.
83. Gispen, W. H., T. B. Van Wimersma Greidanus, C. Waters-
Ezrin, E. Zimmermann, W. A. Krivoy and D. De Wied. Influ-
ence of peptides on reduced response of rats to electric foot
shock after acute administration of morphine. Eur. J. Phar-
mac. 33: 99-105, 1975.
84. Gold, M. S., D. E. Redmond and R. K. Donahedian. The ef-
fects of opiate agonist and antagonist on serum prolactin in
primates: Possible role for endorphins in prolactin regulation.
Endocri nol ogy 105: 284--289, 1979.
85. Goldstein, A. Opioid peptides (Endorphins) in pituitary and
brain. Sci ence 193: 1081-1086, 1976.
86. Goldstein, A., G. T. Pryor, C. S. Otis and F. Larsen. On the
role of endogenous opioids peptides: Failure of naloxone to
influence shock escape threshold in the rat. Li f e Sci. 18: 599-
604, 1976.
87. Goldstein, A. and E. R. Hilgard. Failure of the opiate an-
tagonist naloxone to modify hyphotic analgesia. Proc. hath.
Acad. Sci . U. S. A. 72: 2041-2043, 1975.
88. Grandison, L. and A. Guidotti. Regulation of prolactin release
by endogenous opiates. Nat ur e 270: 357-359, 1977.
89. Grevert, P. and A. Goldstein. Endorphins: Naloxone fails to
alter experimental pain or mood in humans. Sci ence 199:
I 0 9 3 - I 0 9 5 , 1 9 7 8 .
9 0 . G r e v e r t , P . , E . R . B a l a m a n a n d A . G o l d s t e i n . N a l o x o n e e f f e c t
o n a n o c i c e p t i v e r e s p o n s e o f h y p o p h y s e c t o m i z e d a n d a d -
r e n a l e c t o m i z e d m i c e . L i f e S c i . 2 3 : 7 2 3 - 7 2 8 , 1 9 7 8 .
9 1 . G r e v e r t , P . a n d A . G o l d s t e i n . E f f e c t s o f n a l o x o n e o n e x p e r i -
m e n t a l l y i n d u c e d i s c h e m i c p a i n a n d o n m o o d i n h u m a n s u b -
j e c t s . P r o c . n a t n . A c a d . S c i . U . S . A . 7 4 : 1 2 9 1 - 1 2 9 4 , 1 9 7 7 .
9 2 . G r e v e r t , P . a n d A . G o l d s t e i n . S o m e e f f e c t s o f n a l o x o n e o n
b e h a v i o r i n t h e m o u s e . P s y c h o p h a r m a c o l o g y 5 3 : I I I - I 1 3 ,
1 9 7 7 .
9 3 . G r u h e , D . , K . H . V o i g t a n d E . W e b e r . P a n c r e a t i c g l u c a g o n
c e l l s c o n t a i n e n d o r p h i n - l i k e i m m u n o r e a c t i v i t y . H i s t o c h e m i s t o '
5 9 : 7 5 - - 7 9 , 1 9 7 8 .
9 4 . G u i l l e m i n , R . , T . M . V a r g o , J . R o s s i e r , S . M i n i c k , N . L i n g , C .
R i v i e r , W . V a l e a n d F . B l o o m . b - E n d o r p h i n a n d a d r e n o c o r -
t i c o t r o p h i n a r e s e c r e t e d c o n c o m i t a n t l y b y t h e p i t u i t a r y g l a n d .
S c i e n c e 1 9 7 : 1 3 6 7 - 1 3 6 9 , 1 9 7 7 .
51 Gunne, L.-M., L, Lindstrom and L. Terenius. Naloxone-
induced reversal of schizophrenic hallucination. J. Neural
Trans. 40: 13-19, 1977.
96. Hnddox, M. K. and D. H. Russell. beta-Endorphin is a kidney
trophic hormone. Li f e Sci. 25: 615-620, 1979.
97. Hall, K. R. L. and E. Stride. The varying response to pain in
psychiatric disorders. A study in abnormal psychology. Br. J.
Med. Psychol . 27: 48--60, 1954.
98. Hambrook, 3. M., B. A. Morgan, M. J. Rance and C. F. C.
Smith. Mode of deactivation of the enkephalins by rat and
human plasma and rat brain homogenates. Nat ure 262: 782-
783, 1976.
99. Harris, R. A., H. H. Lob, and E. L. Way. Alterations in the
efficacy of naloxone induced by stress, cyclic adenosine
monophosphate, and morphine tolerance. Fur. J. Pharmac. 39:
1-10, 1976.
100. Hayes, R. L., G. J. Bennett, P. G. Newlon and D. J. Mayer.
Behavioral and physiological studies of non narcotic analgesia
in the rat elicited by certain environmental stimuli. Brain Res.
155: 69-90, 1978.
101. Herman, B. H. and J. Panksepp. Effect of morphine and
naloxone on separation distress and approach attachment:
Evidence for opiate mediation of social affect. Pharmac.
Bi ochem. Behav. 9: 213-220, 1978.
102. Heybach, J. P. and J. Vernikos.Danellis. The effect of pituitary
adrenal function on pain sensitivity in the rat. J. Physiol. 283:
331-340, 1978.
103. Hokfelt, T. , R. Elde, O. Johansson, L. Terenius and L. Stein.
The distribution of enkephalin immunoreactive cell bodies in
rat central nervous system. Neurosci . Let t . 5: 25-31, 1977.
104. Holaday, J. W., E. Wei, H. H. Loh and C. H. Li. Endorphin
may function in heat adaptation. Proc. natn. Acad. Sci. U. S.
A. 7S: 2923-2927, 1978.
105. Hollt, V., O. A. Muller and R. Fahlbusch. b-Endorphin in
human plasma: basal and pathologically elevated levels. Li f e
Sci. 25: 37-44, 1979.
106. Hollt, V., R. Przewtocki and A. Herz. beta-Endorphin-like
immunoreactivity in plasma, pituitaries and hypothalamus of
rats following treatment with opiates. Li f e Sci. 23: 1057-1066,
1978.
107. Howe, A. and A. J. Thody. The effect of hypothalamic lesions
of the pars intermedia of the rat pituitary gland. J. Endocr. 46:
201-208, 1970.
108. Ipp, E., R. Dobbs and R. H. Unger. Morphin and beta
endorphin influence the secretion of the endocrine pancreas.
Nat ure 276: 190-191, 1978.
109. Jacob, J. J. C. and K. Ramahadran. Opioid antagonists,
endogenous ligands and nociception. Fur. J. Pharmac. 46:
393-394, 1977.
110. Jacquet, Y. F. Opiate effects after adrenocorticotrophin or
b-endorphin injection in the periaqueductal gray matter of rats.
Sci ence 201: 1032-1034, 1978.
111. Jaffe, J. H. and W. R. Martin. Narcotic analgesics and an-
tagonists. In: The Pharmacol ogi cal Basi s o f Therapeutics.
edited by L. S. Goodman and A. Gilman. New York: Macmil-
lan Co., 1976, pp. 245-283.
112. Janicki, P. and J. Libich. Detection of antagonist activity for
narcotic analgesics in mouse hot-plate test. Pharmac.
Bi ochem. Behav. 10: 623-626, 1979.
113. Janowsky, D. S., D. S. Segal, F. Bloom, A. Abrams and R.
Guiilemin. Lack of effect on naloxone on schizophrenic symp-
toms. Am. J. Psychi at . 134: 926-927, 1977.
114. Jhamandas, K., J. Sawynok and M. Sutak. Enkephalin effects
on release of brain acetylcholine. Nat ur e 269: 433--434, 1977.
115. Joiles, J., V. M. Wiegant and W. H. Gispen. Reduced behavioral
effectiveness of ACTH~_~4 after a second administration: in-
teraction with opiates. Neurosci . Let t . 9: 261-266, 1978.
116. Jones, C. W. and B. T. Picketing. Comparison of the effects of
water deprivation and sodium chloride imbibition on the hor-
mone content of the neurohypophysis of t he rat. J. Physi ol .
203: 449--458, 1969.
84 AMIR, BROWN AND AMIT
t17. Jouhaneau-Bowers, M. and J. Le Magnen. ACTH self-
administration in rats. Pharmac. Bi ochem. Behav. 10: 325--328,
1979.
118, Kaplan, R. and S. D. Glick. Prior exposure to footshock in-
duced naloxone hyperaigesia. Li f e Sci. 24: 2309-2312, 1979.
119. Kastin, A. J., R. D. Olson, A. V. Schally and D. H. Coy. CNS
effects of peripherally administered brain peptides. Li f e Sci.
25: 401--414, 1979.
120. Katz, R. J. ACTH4-t0 antagonism of morphine-induced behav-
ioral activation in the mouse. Eur. J. Pharmac. 53: 393--395,
1979.
121. Katz, R. J. Naltrexone antagonism of exploration in the rat.
Int . J. Neurosci . 9: 49-51, 1979.
122. Katz, R. J. and K. A. Roth. Stress-induced grooming in the rat
-an endorphin mediated syndrome. Neurosci . Let t . 13: 209--
212, 1979.
123. Katz, R. J. and J. Gelbart. Endogenous opiates and behavioral
responses to environmental novelty. Behav. Biol. 24: 338-348,
1978.
124. Keim, K. L. and B. S. Ernest. Physiological and biochemical
concomitants of restraint stress in rats. Pharmac. Bi ochem.
Behav. 4: 289-297, 1976.
125. Kelly, D. D. and R. J. Bodnar. Stress induced analgesia: A
behavioral analysis. Neurosci . Bi ocbehav. Res. , in press.
126. Kobayashi, R. M., M. Palkovits, R. J. Miller, K. J. Chang and
P. Cvatrecasas. Brain enkephalin distribution is unaltered by
hypophysectomy. Lt f e Sci. 22: 527-530, 1978.
127. Kokka, N. and A. S. Fairhurst. Naloxone enhancement of
acetic acid-induced writhing in rats. L(fe Sci. 21: 975-980, 1977.
128. Kosterlitz, H. W. Endogenous opioid peptides and the control
of pain. Psychol . Med. 9: 1-4, 1979.
129. Krieger, D. T. , A. S. Li ot t a, H. Hauser and M. J. Brownstein.
Effect of stress, adrenocorticotropin or corticosteroid treat-
ment, adrenalectomy, or hypophysectomy on hypothalamic
immunoreaetive adrenocorticotropin concentrations. Endocri-
nol ogy 165: 737-742, 1979.
130. Krieger, D. T. and A. S. Liotta. Pituitary hormones in brain:
Where, how and why. Sci ence 205: 366-372, 1979.
131. Krieger, D. T., A. S. Liotta, G. Nicholsen and J. S. Kizer.
Brain ACTH and endorphin reduced in rats with monosodium
glutamate-induced arcuate nuclear lesions. Nat ure 278: 562-
563, 1979.
132. Krieger, D. T., A. Liotta and C. H. Li. Human plasma im-
munoreactive b-lipotropin: correlation with basal and stimu-
lated plasma ACTH concentrations. Li f e Sci. 21: 1771-1778,
1977.
133. Krieger, D. T., A. Liotta and M. J. Brownstein. Presence of
conicotropin in brain of normal and hypophysectomized rats.
Proc. hath. Acad. Sci. U. S. A. 74: 648-652, 1977.
134. Krivoy, W. A., D. C. Kroeger and E. Zimmermann. Neuro-
peptides: influence on acute and chronic effects of opiates.
Psychoneuroendocri nol ogy 2: 43-51, 1977.
135. Krivoy, W., D. Kroeger, A. Taylor and E. Zimmermann. An-
tagonism of morphine by b-melanocyte stimulating hormone
and by tetracosactin. Eur. J. Pharmac. 27: 339-345, 1974.
136. Kuhar, M. J., C. B. Pert and S. H. Snyder. Regional distribu-
tion of opiate receptor binding in monkey and human brain.
Nat ure 245: 447-450, 1973.
137. Kurland, A. A., L. Mccabe, T. E. Hanlon and D. Sullivan. The
treatment of perceptual disturbances in schizophrenia with
naloxone hydrochloride. Am. J. Psychi at . 134: I408-1410,
1977.
138. Kvemansky, R. Transsynaptic and humoral regulation of ad-
renal eathecolamine synthesis in stress. Bi ochem. Pharmac.
23: Suppl. 1, 160-166, 1974.
139. Kvemansky, R., V. K. Weise and I. J. Kopin. Elevation of
adrenal tyrosine hydroxylase and pbenylethanolamine-N-
methyl transferase by repeated immobilization of rats.
Endocri nol ogy if'/: 744-749, 1970.
140. Labella, F., G. Queen and J. Senyshyn. Lipotropin: localiza-
tion by radioimmunoassay of endorphin precursor in pituitary
and brain. Bi ochem. biophys. Res. Commun. 75: 350-351,
1977.
141. Lahti, R. A. and R. J. Collins. Chronic naloxone results in
prolonged increases in opiate binding sites in brain. Eur . . 1
Pharmac. 2: 263-264, 1978.
142. Lal, S., N. P. V. Nair, P. Cervantes, J. Pulman and H. Guyda.
Effect of naloxone or levallorphan on serum prolactin concen-
trations and apomorphine-induced growth hormone secretion.
Acad. psychi at , neurol, scand. 59: 173-179. 1979.
143. LaMotte, C. C., A. Snowman, C. B. Pert and S. H. Snyder.
Opiate receptor binding in rhesus monkey brain: Association
with limbic structure. Brain Res. 155: 374-379. 1978.
144. Lazarus, L. H., L. Ling and R. Guillemin. Beta lipotropin as a
prohormone for the morphinomimetic peptides endorphins and
enkephalins. Proc. natn. Acad. Sci. U. S. A. 73: 2156--2159.
1976.
145. Lebmann, H., N. P. Vasavan Nair and N. S. Kline. beta-
Endorphin and naioxone in psychiatric patients: Clinical and
biological effects. Am. J. Psychi at . 136: 762-766, 1979.
146. Levine, J. D., N. C. Gordon, R. T. Jones and H. L. Fields. The
narcotic antagonist naloxone enhances clinical pain. Nat ure
272: 826--827, 1978,
147. Lewis, R. V., A. S. Stern, J. Rossier, S. Stein and S. Uden-
friend. Putative enkephalin precursor in bovine adrenal
medulla. Bi ochem. bi ophys. Res. Commun. 89: 822--829, 1979.
148. Li, C. H., L. Barnafi, M. Chretien and D. Chung. Identification
and amino acid sequence of/3-LPH from sheep pituitary glands.
Nat ure 208: 1093-1094, 1965.
149. Lien, E. L., R. L. Finichel, V. Garsky, D. Sarantakis and N.
H. Gant. Enkephalin-stimulated prolactin release. L~fe Sei. 19:
837-840, 1976.
150. Lindstrom, L. H., E. Widerlov. L. M. Gunne, A. Wahtstrom
and L. Terenius. Endorphins in human cerebrospinal fluid:
Clinical correlations to some psychotic states. Act a psychiat.
neurol, scand. 57: 153-164, 1978.
151. Liotta, A. S., D. Gildersleeve, M. Brownstein and D. T.
Krieger. In vitro biosynthesis of 31k ACTH/beta endorphin-
like activity by bovine hypothalamus. Proc. nam. Acad. SoL
U. S. A. 76: 1448-1452, 1979.
152. Liotta, A. S., T. Suda and D. T. Krieger. beta-Lipotropin is the
major opioid-like peptide of human pituitary and rat pars dis-
talis: Lack of significant beta-endorphin. Proc. hath. Acad.
Sci. U. S. A. 75: 2950-2954, 1978.
153. Loh, H. H., D. A. Brase, S. Sampath-Khannas, J. B. Mar and
E. L. Way./3-endorphin in vitro inhibition of striatal dopamine
release. Nat ure 264: 567-568, 1976.
154. Lundberg, J. M., B. Hamberger, M. Schultzberg, T. Hokfelt,
P. O. Granberg, S. Efendic, L. Terenius, M. Golstein and R.
Luft. Enkephalin- and somatostalin-like immunoreactivities in
human adrenal medulla and pheochromocytoma. Proc. hath.
Acad. Sci. U. S. A. 76: 4079--4083, 1979.
155. Madden, J. , H. Aki l , R. L. Patrick and J. D. Barchas. Stress-
induced parallel changes in central opioid levels and =pain re-
sponsiveness in the rat. Nat ure 265: 350-360, 1977.
156. Mains, R. E., B. A. Eipper and M. Ling. Common precursor to
corticotropins and endorphins. Proc. hath. Acad. Sci. U. SI A.
74: 3014-3018, 1977.
157. Martin, J. B., G. Tolls, 1. Woods and H, Guyda. Failure of
naloxone to influence physiological growth hormone and pro-
lactin secretion. Brain Res. 168: 210-215, 1979.
158. Mata, M. M., H. Gainer und W. A. Kiee. Effect of dehydration
on the endogenous opiate content of the rat neuro-intermediate
lobe. Li f e Sci. 21:1 I59--i 162, 1977.
159. Mayer, D. J., D. P. Price, J. Barber and A. Rafii. Acupuncture
analgesia: Evidence for activation of a pain inhibitory system
as a mechanism of action. In: Pai n Research and Therapy, Vol.
I., edited by J. J. Bonita and D. C. albe-Fessard. New York:
Raven Press, 1976, pp. 751-755.
160. Mckelvey, G. W. A. The role of the pituitary-adrenal system in
the development of behavioral arousal. Irish J. Med~ Sci. 147:
Suppl. 1, 49-52, 1978.
161. Meites, J., J. F. Bruni, D. A. Van Vugt and A. F. Smith.
Relation of endogenous opioid peptides and mortflaine to neuro-
endocrine functions. Li f e Sci. 24:1325-1335, 1979.
ROLE OF ENDORPHI NS IN STRESS 85
162. Mendelson, J. H., J. Ellingboe, J. C. Keuhnle and N. K. Mello.
Effects of naltrexone on mood and neuroendocrine function in
normal adult males. Psychoneuroendocrinology 3: 231-236,
1979.
163. Merskey, H, and F. G. Spear. Pain: Psychological and Psy-
chiatric Aspect s. London: BaUiere, Tindall and Cox, 1967.
164. Mezey, E., M. Palkovits, E. R. Dekloet, J. Verhoef and D. De
Wied. Evidence for pituitary-brain transport of a behaviorally
potent ACTH analog. Life Sci. 22: 831--838, 1978.
165. Minneman, K. P. and L. L. Iversen. Enkephalin and opiate
narcotics increase cyclic GMP accumulation in slices of the
neostriatum. Nat ure 268: 313-314, 1976.
166. Moroni, F., D. L. Cbeney and E. Costa. Inhibition of acetyl-
choline turnover in rat hippocampus by intra-septal injections
of beta endorphin and morphine. Naunyn-Schmiedebergs
Arch. Pharmac. 299: 149-153, 1977.
167. Murphree, H. B. Introduction to psychotropic drugs. In: Drill's
Pharmacology in Medicine, edited by J. R. DiPalma. New
York: McGraw Hill Co. Inc., 1971, pp. 324-349.
168. Nemeroff, C. B. and A. J. Prange Jr. Peptides and
psychoneuroendocrinoiogy. Archs gen. Psychiat. Chicago 35:
999-1010, 1978.
169. Nicoll, R. A., G. R. Siggins, N. Ling, F. E. Bloom and R.
Guillemin. Neuronal actions of endophins and enkephalins
among brain regions: A comparative microiontophoretic study.
Proc. hath. Acad. Sci. U. S. A. 74: 2584-2588, 1977.
170. North, R. A. Opiates, opioid peptides and single neurons. Life
Sci. 24: 1527-1546, 1979.
171. North, M. A. Naloxone reversal or morphine analgesia but
failure to alter reactivity to pain in the formalin test. Life Sci.
22: 295-302, 1978.
172. Oliver, C., R. S. Michal and J. C. Porter. Hypothalamic,
pituitary vasculature: Evidence for retrograde blood flow in the
pituitary stalk. Endocrinology 101: 598--604, 1977.
173. Orwoll, E., J. W. Kendall, L. Lamorena and R-. McGilvra.
Adrenocorticotropin and melanocyte--stimulating hormone in
the brain. Endocrinology 104: 1845-1852, 1979.
174. Panksepp, J., B. Herman, R. Conner, P. Bishop and J. P.
Scott. The biology of social attachment: Opiates alleviate sep-
aration distress. Biol. Psychiat. 13: 607-618, 1978.
175. Panksepp, J., T. Vilberg, N. J. Bean, D. Coy and A. J. Kastin.
Reduction of distress vocalization in chiks by opiate-like pep-
tides. Brain Res. Bull. 3: 663--667, 1978.
176. Patrick, R. L. and N. Kirshner. Effect of stimulation on the
levels of tyrosine hydroxylase, dopamine beta hydroxylase,
and catecholamines in intact and denervated rat adrenal glands.
Molec. Pharmac. 7: 87-96, 1971.
177. Pelletier, G. and R. Leclerc. Immunohistochemical localization
of adrenocorticotropin in the rat brain. Endocrinology 104:
1426-1433, 1979.
178. Pelletier, G., R. Leclerc, F. Labrie, J. Cote, M. Chretien and
M. Lis. Immunohistochemical localization of b-lipotropic hor-
mone in the pituitary gland. Endocrinology 100: 770--776, 1977.
179. Pert, C. B., M. J. Kuhar and S. N. Snyder. Autoradiographic
localization of the opiate receptor in rat brain. Life Sci. 16:
1849-1854, 1975.
180. Pezalla, P. D., M. Lis, N. G. Seidah and M. Chretien. Lipo-
tropin, melanotropin and endorphin: In vivo catabolism and
entry into cerebrospinal fluid. Can. J. Neurol. Sci. $: 183-188,
1978.
181. Plomp, G. J. J. and J. M. Van Ree. Adrenocorticotrophic hor-
mone fragments mimic the effect of morphine in vitro. Br. J.
Pharmac. 64: 223-227, 1978.
182. Polak, J. M., S. N. Sullivan, S. R. Bloom, P. Facer and A. G.
E. Pearse. Enkephalin-like immunoreactivity in human gas-
trointestinal tract. Lancet 1: 972-974, 1977.
183. Przewlocki, R., V. Hollt, K. H. Goigt and A. Herz. Modulation
of in vitro release of b-endorphin from the separate lobes of the
rat pituitary. Life Sci. 24: 1601-1608, 1979.
184. Rangel, L. Psychiatric aspects of pain. Psychosom. Med. 15:
22-37, 1953.
155. Riley~ A. L., D. A, Zellner and H. J. Duncan. The role of
endorphin in animal learning and behavior. Neurosci.
Biobehav. Rev. 4: 69-76, 1980.
186. Roberts, J. L. and G. Herbert. Characterization of a common
precursor to corticotropin and b-lipotropin: Cell-free synthesis
of the precursor and identification of corticotropin peptides in
the molecule. Proc. natn. Acad. Sci. U. S. A. 74: 4826--4830,
1977.
187. Ross, M., P. A. Berger and A. Goldstein. Plasma beta
endorphin immunoreactivity in schizophrenia. Science 205:
1163-1164, 1979.
188. Ross, M., R. Dingledine, B. M. Cox and A. Gulstein. Distribu-
tion of endorphins (peptides with morphine-like pharmacologi-
cal activity) in pituitary. Brain Res. 124: 523-532, 1977.
189. Rossier, J., E. Battenberg, Q. Pittman, A. Bayon, L. Koda, R.
Miller, R. Guillemin and F. Bloom. Hypothalamic enkephalin
neurones may regulate the neurohypophysis. Nature 227:
653--655, 1979.
190. Rossier, J., R. Gnillemin and F. Bloom. Foot-shock induced
stress decreases LeuS-enkephalin immunoreactivity in rat
hypothalamus. Fur. J. Pharmac. 48: 465--466, 1978.
191. Rossier, J., T. M. Vargo, S. Minick, N. Ling, F. G. Bloom and
R. Guillemin. Regional distribution of b-endorphin and
enkephalin content in rat brain and pituitary. Proc. natn. Acad.
Sci. U. S. A. 74: 5162-5165, 1977.
192. Rossier, J., E. D. French, C. Rivier, N. Ling, R. Guillemin and
F. Bloom. Foot-shock induced stress increases b-endorphin
levels in blood but not brain. Nat ure 270: 618-.620, 1977.
193. Rubinstein, M., S. Stein and S. Udenfriend. Characterization
of pro-opiocortin, a precursor to opioid peptides and cortico-
tropin. Proc. natn. Acad. Sci. U. S. A. 75: 669-671, 1978.
194. Rubin, P., S. Swezey and T. Blaschke. Naloxone lowers
plasma prolacting in brain. Lancet 1: 1293, 1979.
195. Rubinstein, M., S. Stein, L. D. Gerber and S. Udenfriend.
Isolation and characterization of the opioid peptides from rat
pituitary: b-lipotropin. Proc. natn. Acad. Sci. U. S. A. 74:
3052-3055, 1977.
196. Rudman, D. and J. W. Issacs. Effect of intratbecal injections of
melanotropic-lipolytic peptides on the concentration of 3'5'-
cyclic adenosine monophosphate in cerebrospinal fluid.
Endocrinology 97: 1476-1480, 1975.
197. Saffran, M. and A. V. Schally. The status of the corticotropin
releasing factor (CRF). Neuroendocrinology 24: 359-375, 1977.
198. Santagustino, A., D. Cocchi, E. Giagnoni, E. Gori, E. Muller
and S. Ferri. Some relationships between endorphins and
pituitary hormones. In: Advances in Biochemical pharmacol-
ogy, Vol. 18, edited by E. Costa and M. Trabucchi. New York:
Raven Press, 1978, pp. 175-181.
199. Schultzberg, M., T. Hokfelt, L. Terenius, L. G. Elfvin, J. M.
Lundberg, J. Brandt, R. Elde and M. Goidstein. Enkephalin
immunoreactive nerve fibers and cell bodies in sympathetic
ganglia of the guinea-pig and rat. Neuroscience 4: 249-270,
1979.
Schultzberg, M., C. F. Dreyfus, M. D. Gershon, T. Hokfelt, R.
Eide, G. Niison, S. Said and M. Goldstein. VIP-, enkephalin-,
substance P-, and somatostatin-like immunoreactivity in
neurons intrinsic to the intestine: Immunohistochemical evi-
dence from organotypic tissue cultures. Brain Res. 155: 239-
248, 1 9 7 8 .
Schultzberg, M., J. M. Lundberg, T. Hokfelt, L. Terenius, J.
Brandt, R. P. Elde and M. Goidstein. Enkephalin-like im-
munoreactivity in gland cells and nerve terminals of the adrenal
medulla. Neuroscience 3:1169-1186, 1978.
Schultzberg, M., T. Hokfelt, J. M. Lundberg, L. Terenius,
L.-G. Elfvin and R. EIde. Enkephalin-like immunoreactivity in
nerve terminals in sympathetic gangiia and adrenal medulla and
in adrenal medullary gland cells. Act a physiol, scand. 103:
475-477, 1978.
Selye, H. The story of the adaptation syndrome. Act a Med.
Montreal, 1952.
Selye, H. Stress. The physiology and pathology of exposure to
stress. Act a Med. Montreal, 1950.
200.
201.
202.
203.
204.
86 AM1R, BROWN AND AMI ' I
205. Shaar, C. J. , R. C. A. Frederi ckson, N. B. Dininger and L.
Jackson. Enkephalin analogues and naloxone modulate the re-
lease of growth hormone and prolactin-evidence for regulation
by an endogenous opioid peptide in brain. Li f e Sci. 21: 853-
860, 1977.
206. Shanker, G. and R. K. Sharma. b-Endorphin stimulates cor-
ticosterone synthesis. Bi ochem. bi ophys. Res. Commun. 86:
1-5, 1979.
207. Simantov, R. and S. H. Snyder. Opiate recept or binding in the
pituitary gland. Brain Res. 124: 178-184, 1977.
208. Simantov, R., M. J. Juhar, G. R. Uhl and S. H. Snyder. Opioid
peptide enkephalin: Immunohistochemical mapping in rat cen-
tral nervous system. Proc. natn. Acad. Sci. U. S. A. 74: 2167-
2171, 1977.
209. Singer, G. Psychological or physiological analgesics: A recon-
ciliation. Bi obehav. Rev. 1: 13%139, 1977.
210. Stewart, J. and R. Eikelboom. Stress masks the hypothermic
effect of naloxone in rats. Li f e Sci. 25: 1165-1172, 1979.
211. Sullivan, S. N. , S. R. Bloom and J. M. Polak. Enkephalin in
peripheral neuroendocri ne tumors. Lancet 1: 986-987, 1978.
212. Tang, A. H. and R. J. Collins. Enhanced analgesic effects of
morphine after chronic administration of naioxone in the rat.
Eur. J. Pharmac. 47: 473--474, 1978.
213. Taube, H. D. , E. Borowski, T. Endo and K. Starke.
Enkephalin: a potential modulator of noradrenaline release in
rat brain. Eur. J. Pharmac. 38: 377-380, 1976.
214. Terenius, L. , A. Wahlstrom and H. Agren. Nal oxone (Narcan)
treatment in depression: Clinical observat i on and effects on
CSF endorphins and monoamine metabolites. Psychophar-
macol ogy 54: 31-33, 1977.
215. Terenius, L. Somatostatin and ACTH are peptides with partial
antagonist-like selectivity for opiate receptors. Eur. J. Phar-
mac. 38: 211-213, 1976.
216. Terenius, L. , A. Wahlstrom, L. Li ndst rom and E. Widerlov.
Increased CSF levels of endorphins in chronic psychosis.
Neurosi c. Let t . 3: 157-162, 1976.
217. Terenius, L. Effect of peptides and amino acids on dihy-
dromorphine binding to t he opiate receptor. J. Pharm. Phar-
mac. 27: 450-452, 1975.
218. Terenius, L. , W, H. Gispen and D. De Wied. ACTH-i i ke pep-
tides and opiate receptors in the rat brain: Structure activity
studies. Eur. J. Pharmac. 33: 395-399, 1975.
219. Teschemacher, H. J. , K. E. Opheim, B. M. Cox and A. Gold-
stein. A peptide-like substance from pituitary that acts like mor-
phine I. isolation. Life Sci. 16: 1771-1776, 1975.
220. Thoenen, H. Induction of tyrosine hydroxyl ase in peripheral
and central adrenerglc neurons by cold exposure of rats. Na-
ture 228: 861-862, 1970.
221. Torda, C. Effects of recurrent postnatal pain-related stressful
event s on opiate receptor-endogenous ligand system.
Psychoneu_roend?crinology 3: 85-91, 1978.
222. Tseng, L. F. , H. H. Loh and C. H. Li. b-Endorphin as a potent
analgesic by intravenous injection. Nat ure 263: 239-240, 1976.
223. Vale, W. , J. Ri vi er, R. Guillemin and C. Rivier. Effect of
purified CRF and ot her substances on the secretion of ACTH
and b-endorphin-like immunoactivities by cultured anterior or
neurointermediate pituitary cells. In: Cent ral Nervous Syst em
Ef f ect s o f Hypot hal ami c Hormones and ot her Pept i des, edited
by Collu et al. New York: Raven Press, 1979.
224. Vale, W., C. Rivier, L. Yang, S. Minick and R. Guillemin.
Effects of purified hypothaiamic corticotropin releasing fact or
and ot her substances on the secretion of adrenocorticotropin
and b-endorphin-like immunoactivities in vitro. Endocri nol ogy
103: 1910-1915, 1978.
225. Van Loon, G. R. and E. B. Souza. Devel opment of tolerance to
the ACTH releasing effects of bet a endorphin. Res. Commun.
Chem. Pat hol . Pharmac. 22: 203-204, 1978.
226. Van Vugt, D. A. , J. F. Bruni and J. MeRes. Nal oxone inhibi-
tion of stress-induced increase in prolactin secretion. Li f e Sci.
22: 85-90, 1978.
227. Verhoef, J. , M. Paikovits and A. Witter. Distribution of a be-
haviorally highly potent ACTH4_9 analog in rat brain after
intraventricular administration. Brain Res. 126: 89-104, 1979.
228. Verebey, K. , J. Vol avka and D. Clouet. Endorphins in psy-
chiatry. Archs gen. Psychi at . Chi cago 35: 877-888, 1978.
229. Vernmikos-Danellis, J. Estimation of corticotropin releasing
activity of rat hypothalamus and neurohypophysis before and
after stress. Endocri nol ogy 75: 514--520. 1964.
230. Volavka, J. , A. Mallya, S. Baig and J. Perez-CrueL Naloxone
in chronic schizophrenia. Sci ence 196: 1227-1228, 1977.
231. Wardlaw, S. L. and A. G. Frantz. Measurement of b-endorphin
in human plasma. J. ctin. Endocr. 18: 176-180. 1979.
232. Watson, S. J. and H. Akil. b-endorphin and b-MSH: Common
cells of origin and binding properties. Soc. neurosci. Abst r. 5:
1840, 1979.
233. Watson, S. J. , H. Akil, P. A. Berger and J. D, Barchas. Some
observations on the opiate peptides and schizophrenia. Archs
gen. Psychi at . Chi cago 36: 35-41, 1979.
234. Watson, S. J. , P. A. Berger, H. Akil, M. J. Mills and J. D.
Barchas. Effects of naloxone on schizophrenia: Reduction in
hallucination in subpopulation of subjects. Sci ence 201: 73-76,
1979.
235. Watson, S. J. , H. Akil, C. W. Richard I l l and J. D. Barchas.
Evi dence for two separate opiate peptide neuronal systems.
Nat ure 275: 226-228, 1978.
236. Watson, S. J. , C. W. Richard I I l and J. D. Barchas. Ad-
renocorticotropin in rat brain: l mmunocyt ochemi cal localiza-
tion in cells and axons. Sci ence 200: 1180-1182, 1978.
237. Watson, S. J. , H. Akil, S. O. Sullivan and J. D. Barchas. Im-
munocyt ochemi cal localization of methionine enkephalin. Li f e
Sci. 21: 733-738, 1977.
238. Weber, E. , K. H. Voigt and R. Martin. Concomitant storage of
ACTH- and endorphin-like immunoreactivity in secretory
granules of anterior pituitary corticotrophs. Brain Res. 157:
385-390, 1978.
239. Waitzman, R. E. , D. A. Fisher, S. Minick, N. Ling and R.
Guillemin. b-Endorphin stimulates secretion of arginine vaso-
pressin in vivo. Endocri nol ogy 101: 1643-1646, 1977.
240. Wesche, D. L. and R. C. A. Frederickson. Diurnal differences
in opioid peptide levels correlated with nociceptive sensitivity.
Li f e Sci. 24: 1861-1868, 1979.
241. Wiedemann, E. , T, Satio, J. A, Linfoot and C. H. Li. Specific
radioimmunoassay of human beta-endorphin in unextracted
plasma. J. olin. Endocr. Met ab. 49: 478-480, 1979.
242. Wiegant, V. M. , W. H. Gispen, L. Terenius and D. De Wied.
ACTH-iike peptides and morphine: interaction at the level of
the CNS. Psychoneuroendocri nol ogy 2: 63--69, t977.
243. Wiegant, V. M., A. J. Dunn, P. S. Schotman and H. Gispen.
ACTH-like neurotropic peptides: Possible regulators of rat
brain cyclic AMP. Brain Res. 168: 565-584, 1979.
244. Winter, C. A. and L. Flataker. The effect of corticosterone,
desoxycort i cost erone and adrenal-corticotrophic hormone
upon the responses of animals to analgesic drugs. J. Pharmac.
exp. Ther. 103: 93-105, 1951.
245. Wong, C. -L. and G. A. Bentley. The effect of stress and ad-
renalectomy on morphine analgesia and naloxone potency in
mice. Eur. J. Pharmac. 56: 197-205, 1979.
246. Wood, P. L. , D. Malthe-Sorenssen, D. L. Cheney and G.
Costa. Increase of hippocampal acetylcholine t urnover rate
and stretching yawning syndrome elicited by alpha-MSH and
ACTH. Lift, Sci. 22: 673-678, 1978.
247. Yasukawa, N. , H. Mouder, S. D. Michael and J. J. Christian.
Opiate antagonist counteracts reproductive inhibition by por-
cine ACTH extract. Li f e Sci. 22: 1381-1390, t978.
248. Yoshizaki, T. Effect of histamine, bradykinin and morphine on
adrenalin release from rat adrenal gl and. . l ap. J. Pharmac. 23:
695-699, 1973.
249. Zimmermann, E. and W. Krivoy. Antagonism helwecn mor-
phine and the polypeptides ACTH, ACTHI-24 and b-MSH in
the nervous system. Prog. Brain Res. 39: 383--392, t973.